Lin Yan

Prof. Lin Yan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
MGMengkang Gao
Mengkang Gao
YWYusui Wang
Yusui Wang
LLLanqi Liu
Lanqi Liu
ZQZhenrui Qiao
Zhenrui Qiao
LYLin Yan
Lin Yan
Introduction: Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel with high permeability to calcium, which is widely expressed in the central nervous system (CNS) and peripheral nervous system. Since the TRPV1 was molecularly cloned more than 20 years ago, a series of research activities have been carried out on the possibility of new drugs. Areas covered: This review summarizes the patents on TRPV1 regulators (including agonists and antagonists) that were published during 2014–present and predicts the development direction in the future. The patent description is organized according to the applicant company and focuses on the representative compounds and their in vitro and in vivo data. Expert opinion: At present, TRPV1 is considered to be a molecular integrator of a broad range of chemical and physical stimuli. The desensitization of nociceptive neurons caused by TRPV1 agonists and the pharmacological blockade of TRPV1 by powerful small molecular antagonists are different treatments, both of which have analgesic effects. Unfortunately, TRPV1 modulators have suffered from adverse effects related to the role of TRPV1 channel in body temperature regulation and noxious heat sensation. What we need to know is whether these adverse effects are on-target (unavoidable), and whether chemical modification can be used to avoid or reduce these adverse reactions in the process of designing drug molecules, so as to develop a TRPV1 regulator with potent analgesic effect and no obvious adverse effects. Despite the difficulties and roadblocks, TRPV1 modulators remain powerful tools in pain research and represent promising therapeutic agents.

10 October 2011 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
FZFangli Zhao
Fangli Zhao
WZWen Zhang
Wen Zhang
YYYuanyong Yang
Yuanyong Yang
YPYuanhang Pan
Yuanhang Pan
WCWenchao Chen
Wenchao Chen
ZJZhiyong Jiang
Zhiyong Jiang

1 October 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
JHJing Hu
Jing Hu
MGMengkang Gao
Mengkang Gao
YZYang Zhang
Yang Zhang
YWYusui Wang
Yusui Wang
ZQZhenrui Qiao
Zhenrui Qiao
HQHai Qian
Hai Qian

10 October 2023 in Analytica Chimica Acta
Verified
Journal Article
Closed access
BWBingxin Wang
Bingxin Wang
JSJunzhuo Shi
Junzhuo Shi
NGNing Guo
Ning Guo
LSLulian Shao
Lulian Shao
WZWeibin Zhai
Weibin Zhai
LYLin Yan
Lin Yan

1 May 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CNCunbin Nie
Cunbin Nie
QLQifei Li
Qifei Li
YQYue Qiao
Yue Qiao
JHJing Hu
Jing Hu
MGMengkang Gao
Mengkang Gao
HQHai Qian
Hai Qian

2 February 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZQZhenrui Qiao
Zhenrui Qiao
SLShuyu Liu
Shuyu Liu
WZWeibin Zhai
Weibin Zhai
LJLei Jiang
Lei Jiang
YMYunmeng Ma
Yunmeng Ma
LYLin Yan
Lin Yan